Sept. 14, 2022
WASHINGTON, D.C. – Nelson Mullins represented Maxpro Capital Acquisition Corp. (“Maxpro”) in its special purpose acquisition company (“SPAC”) deal with Apollomics Inc. (“Apollomics”). The deal has a value of $899 million and is expected to be completed in the first quarter of 2023. The combined company would trade on NASDAQ under the ticker symbol “APLM.”
The Nelson Mullins team was led by partners Andy Tucker and Mike Bradshaw, and associate Kaylen Loflin. They were supported by partners Christopher Hanson, Anthony Laurentano, Wells Hall, Tim Wagner, Colleen Pleasant Kline, Cara Ludwig, Patricia Markus, and Henry Burwell.
Maxpro is a blank check company formed for the purposes of effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare and technology industries.
Apollomics is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer.
Tucker is a corporate and securities advisor to growing companies, particularly in the technology and government contracting sectors. He assists his clients with a broad variety of transactional support, including venture capital and private equity transactions, joint ventures, mergers and acquisitions, and public and private securities offerings.
Bradshaw focuses his practice on corporate finance, securities offerings and regulation, and related matters. He represents both investment banks and issuers in a wide variety of public and private offerings, including initial public offerings, follow-on offerings, Rule 144A offerings of equity or debt, and private placements. He has worked on numerous offerings for business development companies, banks, financial services companies, REITs, and financial technology companies, among others.
Loflin focuses her practice on securities and corporate law. She represents both investment banks and issuers in a wide variety of public and private offerings, including initial public offerings, follow-on offerings, Rule 144A offerings of equity or debt, and private placements.
Established in 1897, Nelson Mullins is an Am Law 100 firm of more than 930 attorneys and government relations professionals with offices in 15 states and Washington, D.C. For more information on the firm, go to www.nelsonmullins.com.
These materials have been prepared for informational purposes only and are not legal advice. This information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Internet subscribers and online readers should not act upon this information without seeking professional counsel.